Atlas Trials

Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours

Clinical trial NCT01194193 · WITHDRAWN

Trial details

NCT number
NCT01194193
Sponsor
AstraZeneca
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
CancerAdvanced Solid TumoursLymphomas
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.